HSA
CRL icon

Hussman Strategic Advisors’s Charles River Laboratories CRL Stock Holding History

Hussman Strategic Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-250
Closed -$33K – 208
2019
Q3 		$33K Buy
+250
New +$33.5K 0.01% 194
2019
Q2 		– Sell
-15,000
Closed -$2.18M – 194
2019
Q1 		$2.18M Sell
15,000
-10,000
-40% -$1.31M 0.53% 74
2018
Q4 		$2.83M Buy
+25,000
New +$3.13M 0.68% 42

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Hussman Strategic Advisors's CRL Position: Q4 2019 in Review

Hussman Strategic Advisors sold out of Charles River Laboratories (CRL) in Q4 2019, closing a stake of 250 shares — an estimated $33K sold.

Hussman Strategic Advisors first reported a position in CRL in Q4 2018 and held it in 3 quarters. The position peaked at $2.83M in Q4 2018. 413 funds tracked by Wall St. Rank hold CRL as of Q4 2019.

  • Hussman Strategic Advisors reported no remaining Charles River Laboratories position as of Q4 2019 after selling out during the quarter.
  • Hussman Strategic Advisors sold 250 Charles River Laboratories shares in Q4 2019, an estimated $33K.
  • Hussman Strategic Advisors first reported a position in Charles River Laboratories in Q4 2018 and held it in 3 quarters.
  • Hussman Strategic Advisors's Charles River Laboratories position peaked at $2.83M in Q4 2018.
  • 413 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2019.

Based on Hussman Strategic Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.